Triggering method in assisted reproduction alters the cumulus cell transcriptome.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 21 09 2018
revised: 18 03 2019
accepted: 21 03 2019
pubmed: 30 5 2019
medline: 22 8 2020
entrez: 30 5 2019
Statut: ppublish

Résumé

How does the choice of triggering final oocyte maturation affect the cumulus cell transcriptome? Sixty patients undergoing gonadotrophin-releasing hormone antagonist (GnRH-ant) IVF cycles were recruited for this nested case-control study. Patients were stratified into three subgroups based on their ovarian reserve (high, normal and low). Triggering final oocyte maturation was accomplished by either single trigger (with human chorionic gonadotrophin [HCG] only or gonadotrophin-releasing hormone agonist [GnRH-ag] only) or dual trigger combining HCG and GnRH-ag. The choice of trigger was at the discretion of the treating physician. Within each group patients receiving a dual trigger were matched by demographic and pre-stimulation parameters with patients receiving a single trigger. The matching was performed to minimize the biological variability within each subgroup. Thirty patients were included in the final analysis. Cumulus cells were stripped away from the retrieved oocytes. Cumulus cells from three sibling oocytes were pooled, the RNA extracted and libraries prepared. Next-generation sequencing was performed on all samples. Dual triggering supports key ovarian pathways of oocyte maturation and extracellular matrix remodelling, while attenuating vasculo-endothelial growth and providing antioxidant protection to the growing follicles. This is the first study to delineate key transcriptomic changes under dual triggering of final oocyte maturation, across different patient populations. The findings underline the need for larger-scale studies validating transcriptomic effects of methods for triggering final oocyte maturation. Furthermore, there is a need for large-scale clinical randomized controlled studies to relate the findings of this study with clinical outcomes.

Identifiants

pubmed: 31138495
pii: S1472-6483(19)30372-4
doi: 10.1016/j.rbmo.2019.03.213
pii:
doi:

Substances chimiques

Antioxidants 0
Chorionic Gonadotropin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

211-224

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Noga Fuchs Weizman (N)

CReATe Fertility Centre, Toronto, ON, Canada.

Brandon A Wyse (BA)

CReATe Fertility Centre, Toronto, ON, Canada. Electronic address: brandon@createivf.com.

Itai Gat (I)

CReATe Fertility Centre, Toronto, ON, Canada.

Hanna Balakier (H)

CReATe Fertility Centre, Toronto, ON, Canada.

Mugundhine Sangaralingam (M)

CReATe Fertility Centre, Toronto, ON, Canada.

Julieta Caballero (J)

CReATe Fertility Centre, Toronto, ON, Canada.

Shlomit Kenigsberg (S)

CReATe Fertility Centre, Toronto, ON, Canada.

Clifford L Librach (CL)

CReATe Fertility Centre, Toronto, ON, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada; Department of Physiology, University of Toronto, Toronto, ON, Canada; Department of Gynecology, Women's College Hospital, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH